Skip to main content
High RiskFDAfda-F-1599-2017UNDECLARED ALLERGEN

The Sweet Dessert Corp., Cheesecake Guayaba (Guava), Peso Neto (Net Weight) 3oz and 4oz and 4oz (large label)., Carr. 173 Km 7.1 Bo. Sumi...

Category
Units Affected
2,000
Recall Date
December 9, 2016
Issuing Agency
Hazard
Undeclared Allergen

FDA Recall Notice

Source: U.S. Food and Drug Administration (FDA) — official FDA notice for recall FDA-F-1599-2017.

Undeclared Milk: Milk (small label 3oz and 4oz and large label 4oz) Undeclared food color: Red #40 (small label 3oz and 4oz)

Corrective Action (per FDA)

Source: U.S. Food and Drug Administration (FDA) — official FDA notice for recall FDA-F-1599-2017.

Recall terminated by FDA.

✅ What you should do

  1. Stop using the product if you own it.
  2. Check the model number, lot code, or sell-by date against the recall notice above.
  3. Contact Sweets & Desserts, Inc. or the retailer where you bought it for a refund, replacement, or repair.
  4. For the most current official instructions, visit the FDA recall page.
  5. If you've been hurt by this product, report the incident to FDA.

Consumer Contact (per FDA)

Source: U.S. Food and Drug Administration (FDA) — official FDA notice for recall FDA-F-1599-2017.

Sweets & Desserts, Inc.

FDA

About the U.S. Food and Drug Administration

The FDA regulates drugs, medical devices, food, cosmetics, and tobacco. Adverse event reports and recall notices are the main public safety signal.

Visit FDA.gov →

📣 Report a food, supplement, or cosmetic problem to the FDA

If you had a reaction, found contamination, or experienced a labeling problem with this product, report it to the FDA. The agency uses consumer reports to track emerging safety signals and trigger recalls.

How to report to FDAFile a report at FDA

Sweets & Desserts, Inc. Recall FAQ

Sweets & Desserts, Inc. is the subject of a dairy safety report: The Sweet Dessert Corp., Cheesecake Guayaba (Guava), Peso Neto (Net Weight) 3oz and 4oz and 4oz (large label)., Carr. 173 Km 7.1 Bo. Sumi.... The notice was published on December 9, 2016 by the U.S. Food and Drug Administration (FDA). Approximately 2,000 units are potentially affected.